Archives
- 2025-11
 - 2025-10
 - 2023-07
 - 2023-06
 - 2023-05
 - 2023-04
 - 2023-03
 - 2023-02
 - 2023-01
 - 2022-12
 - 2022-11
 - 2022-10
 - 2022-09
 - 2022-08
 - 2022-07
 - 2022-06
 - 2022-05
 - 2022-04
 - 2022-03
 - 2022-02
 - 2022-01
 - 2021-12
 - 2021-11
 - 2021-10
 - 2021-09
 - 2021-08
 - 2021-07
 - 2021-06
 - 2021-05
 - 2021-04
 - 2021-03
 - 2021-02
 - 2021-01
 - 2020-12
 - 2020-11
 - 2020-10
 - 2020-09
 - 2020-08
 - 2020-07
 - 2020-06
 - 2020-05
 - 2020-04
 - 2020-03
 - 2020-02
 - 2020-01
 - 2019-12
 - 2019-11
 - 2019-10
 - 2019-09
 - 2019-08
 - 2019-07
 - 2019-06
 - 2019-05
 - 2019-04
 - 2018-11
 - 2018-10
 - 2018-07
 
- 
                
          
hydroxydopamine OHDA is a selective catecholaminergic neurot
2023-05-29

6-hydroxydopamine (6-OHDA) is a selective catecholaminergic neurotoxin mainly used to generate lesions in the nigrostriatal pathway in rats (Ungerstedt, 1968). The most common use of 6-OHDA is via unilateral injection into the rat medial forebrain bundle (MFB). DA depletion, nigral DA cell loss, and
 - 
                
          
As shown in B the recombinant
2023-05-29

As shown in B, the recombinant human 15-LOX-1 (30nM) showed a time-dependent increase in fluorescent signal, and signal development was almost completed within 20min in the presence of 50μM arachidonic abk receptor and 5μM DHR. For both purified enzyme and cell lysates, the enzyme activities disapp
 - 
                
          
The LOX hydroxide metabolites are
2023-05-29

The 15-LOX hydroxide metabolites are converted to secondary lipid mediators such as lipoxin A4 from 15-HETE and protectin D1/resolvin D1 from 17-HDoHE [45] (Fig. S3). Importantly, all of these secondary lipid mediators have anti-inflammatory and pro-resolving properties [46], [47], [48]. Lipoxin A4
 - 
                
          
br Conflicts of interest br Introduction
2023-05-29

Conflicts of interest Introduction Arginase catalyzes the reaction in which l-arginine is converted to l-ornithine and urea. In humans, two arginase isoenzymes have been identified, arginase 1 and arginase 2, that differ in cellular location and tissue distribution [1]. Both arginase enzymes a
 - 
                
          
The reception of antiangiogenic treatment in neuro oncology
2023-05-26

The reception of antiangiogenic treatment in neuro-oncology has yet to achieve the wide success rapidly accomplished for other malignancies. In 1984, mutated receptor tyrosine kinase became a culprit for aberrant tumorigenesis signal, providing a target for monoclonal Domiphen Bromide (mAbs) and sm
 - 
                
          
br Valsartan It is another ARB with
2023-05-26

Valsartan It is another ARB, with several reports for its beneficial effects on CV system both in preclinical and clinical studies. Valsartan treatment has reduced the levels of pentraxin 3, a marker for inflammation and is well tolerated in terms of side effects [17]. In BSCORE study, 90-day se
 - 
                
          
Recent results suggest that TARPs are not the only auxiliary
2023-05-26

Recent results suggest that TARPs are not the only auxiliary AMPAR subunits. Using a proteomic strategy (affinity purification of native AMPAR complexes followed by mass-spectrometric analysis), cornichon-related proteins (CNIHs) have been recently identified as components of the AMPAR protein micro
 - 
                
          
Initially DPP DPP and prolyl
2023-05-26

Initially, DPP4, DPP7, and prolyl tripeptidyl peptidase A (PtpA) were the only exopeptidases identified in P. gingivalis. These share substrates according to their altered specificities, as DPP4 is highly specific for Pro at the penultimate position from the N-terminus (P1 position), though it acce
 - 
                
          
br AHR mediates TCDD toxicity and wasting syndrome TCDD caus
2023-05-26

AHR mediates TCDD toxicity and wasting syndrome TCDD causes numerous toxicities in laboratory animals, including teratogenesis, hepatic steatosis, thymic atrophy, immune dysfunction and a lethal wasting syndrome [17]. The dose-dependent sensitivity to TCDD-induced toxicities varies widely among l
 - 
                
          
br Adiponectin in prostate cancer PC was
2023-05-26

Adiponectin in prostate cancer PC was documented as the leading type of malignancy in males in the US with respect to both the estimated number of cases (22,800) and deaths (27,540) (Siegel et al., 2016). Studies have reported an association between low APN levels and the progression of PC (Micha
 - 
                
          
B lymphocytes are found in blood
2023-05-26

B lymphocytes are found in blood, lymph nodes, spleen and tonsil and other mucosal tissues [110]. These cells originate in the bone marrow from a common progenitor shared with T, NK, and some DC subsets [111]. Progenitor Octyl-α-ketoglutarate progress through the early stages of maturation, rearran
 - 
                
          
MMP-2 Inhibitor I mg In earlier experiments on snails a beha
2023-05-26

In earlier experiments on snails, a behavioral model was employed of certain food rejection to study the mechanisms of the reconsolidation of long-term associative memory. It was found that conditioned food stimuli (reminder) presentation, combined with injections of NMDA glutamate receptor antagoni
 - 
                
          
br Aromatase the key enzyme for estrogen
2023-05-26

Aromatase: the key enzyme for estrogen formation in adipose tissue Estrogens are synthesized from androgens by aromatase, a member of the cytochrome P450 superfamily, which is the rate-limiting enzyme in estrogen biosynthesis (Santen et al, 2009, Simpson et al, 1994). At the cellular level, aroma
 - 
                
          
The most common adverse effects were ARIA which
2023-05-25

The most common adverse effects were ARIA, which occurred at higher levels than in any previous anti-Aβ mAb study. ARIA-E was observed at some point during the trial in no participants in the placebo group compared with 1 (3%), 2 (6%), 11 (37%), and 13 (41%) participants receiving 1, 3, 6, and 10 mg
 - 
                
          
br Results We set out
2023-05-25

Results We set out to identify in an unbiased manner a set of candidate “scaling factors” that might participate in transcription-dependent synaptic scaling up. The ex vivo slice and profiling studies were conducted on HsCt5 mice (described later) at postnatal day (P) 14 to P15, an age at which s